Max Robotics — Global Service Robot Directory + US Certification

About

Roberta Castriconi is a leading researcher in the field of radiation oncology, with a primary focus on ultra-hypofractionated radiotherapy and stereotactic body radiation therapy (SBRT) for prostate cancer. Her work centers on developing innovative, patient-centric treatment protocols that dramatically reduce treatment duration while maintaining or improving efficacy and safety. Castriconi’s major contribution is the conceptualization and clinical investigation of the PRO-FAST protocol, a pioneering single-fraction, urethral-sparing, HDR-like robotic SBRT approach that aims to compress the entire prostate cancer treatment into a single day. This work represents a paradigm shift in radiotherapy, addressing the critical need for more convenient and accessible care without compromising oncological outcomes. While her most-cited paper, detailing the PRO-FAST protocol, is newly published in 2025 and currently has 1 citation, its foundational importance is already recognized within the field. Castriconi’s research is notable for its bold ambition to redefine standard-of-care fractionation schedules, potentially improving patient quality of life and treatment compliance. Her ongoing work promises to shape the future of prostate cancer management, making her a key figure to watch in the evolution of precision radiotherapy.